Logo image of AHG

AKSO HEALTH GROUP (AHG) Stock Fundamental Analysis

NASDAQ:AHG - Nasdaq - US98422P1084 - ADR - Currency: USD

1.3729  +0.02 (+1.7%)

Fundamental Rating

2

AHG gets a fundamental rating of 2 out of 10. The analysis compared the fundamentals against 102 industry peers in the Health Care Providers & Services industry. The financial health of AHG is average, but there are quite some concerns on its profitability. AHG does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

AHG had negative earnings in the past year.
AHG had a negative operating cash flow in the past year.
AHG had negative earnings in each of the past 5 years.
In multiple years AHG reported negative operating cash flow during the last 5 years.
AHG Yearly Net Income VS EBIT VS OCF VS FCFAHG Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M -50M

1.2 Ratios

With a Return On Assets value of -4.44%, AHG is not doing good in the industry: 66.67% of the companies in the same industry are doing better.
The Return On Equity of AHG (-4.72%) is comparable to the rest of the industry.
Industry RankSector Rank
ROA -4.44%
ROE -4.72%
ROIC N/A
ROA(3y)-13.47%
ROA(5y)-47.73%
ROE(3y)-53.44%
ROE(5y)-101.9%
ROIC(3y)N/A
ROIC(5y)N/A
AHG Yearly ROA, ROE, ROICAHG Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -50 -100 -150 -200

1.3 Margins

The Gross Margin of AHG (5.06%) is worse than 80.00% of its industry peers.
The Profit Margin and Operating Margin are not available for AHG so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 5.06%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
AHG Yearly Profit, Operating, Gross MarginsAHG Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -200 -400 -600 -800 -1K

More info and screens

6

2. Health

2.1 Basic Checks

AHG has a better debt/assets ratio than last year.
AHG Yearly Shares OutstandingAHG Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 5M 10M 15M 20M 25M
AHG Yearly Total Debt VS Total AssetsAHG Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M

2.2 Solvency

An Altman-Z score of 26.47 indicates that AHG is not in any danger for bankruptcy at the moment.
AHG's Altman-Z score of 26.47 is amongst the best of the industry. AHG outperforms 99.05% of its industry peers.
A Debt/Equity ratio of 0.03 indicates that AHG is not too dependend on debt financing.
The Debt to Equity ratio of AHG (0.03) is better than 80.95% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.03
Debt/FCF N/A
Altman-Z 26.47
ROIC/WACCN/A
WACCN/A
AHG Yearly LT Debt VS Equity VS FCFAHG Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M -50M 100M

2.3 Liquidity

AHG has a Current Ratio of 8.19. This indicates that AHG is financially healthy and has no problem in meeting its short term obligations.
AHG has a better Current ratio (8.19) than 99.05% of its industry peers.
A Quick Ratio of 8.18 indicates that AHG has no problem at all paying its short term obligations.
The Quick ratio of AHG (8.18) is better than 99.05% of its industry peers.
Industry RankSector Rank
Current Ratio 8.19
Quick Ratio 8.18
AHG Yearly Current Assets VS Current LiabilitesAHG Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M

More info and screens

0

3. Growth

3.1 Past

The earnings per share for AHG have decreased strongly by -220.00% in the last year.
The Revenue for AHG has decreased by -81.71% in the past year. This is quite bad
Measured over the past years, AHG shows a decrease in Revenue. The Revenue has been decreasing by -8.18% on average per year.
EPS 1Y (TTM)-220%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%98.21%
Revenue 1Y (TTM)-81.71%
Revenue growth 3YN/A
Revenue growth 5Y-8.18%
Sales Q2Q%675.98%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
AHG Yearly Revenue VS EstimatesAHG Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2022 2023 2024 20M 40M 60M 80M 100M
AHG Yearly EPS VS EstimatesAHG Yearly EPS VS EstimatesYearly EPS VS Estimates 2018 1 2 3 4

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

AHG reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
AHG Price Earnings VS Forward Price EarningsAHG Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
AHG Per share dataAHG EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.2 0.4

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

AHG does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

AKSO HEALTH GROUP

NASDAQ:AHG (4/25/2025, 8:00:00 PM)

1.3729

+0.02 (+1.7%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)12-04 2023-12-04
Earnings (Next)N/A N/A
Inst Owners0.08%
Inst Owner Change-28.5%
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap547.54M
AnalystsN/A
Price TargetN/A
Short Float %0.03%
Short Ratio1.21
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 226.79
P/FCF N/A
P/OCF N/A
P/B 2.73
P/tB 6.22
EV/EBITDA N/A
EPS(TTM)-0.11
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.01
FCFYN/A
OCF(TTM)-0.01
OCFYN/A
SpS0.01
BVpS0.5
TBVpS0.22
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -4.44%
ROE -4.72%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 5.06%
FCFM N/A
ROA(3y)-13.47%
ROA(5y)-47.73%
ROE(3y)-53.44%
ROE(5y)-101.9%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover0.01
Health
Industry RankSector Rank
Debt/Equity 0.03
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 8.19
Quick Ratio 8.18
Altman-Z 26.47
F-Score4
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-220%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%98.21%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-81.71%
Revenue growth 3YN/A
Revenue growth 5Y-8.18%
Sales Q2Q%675.98%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y39.59%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y141.57%
FCF growth 3Y-48.79%
FCF growth 5YN/A
OCF growth 1Y141.57%
OCF growth 3Y-48.79%
OCF growth 5YN/A